cached image

George R. Breese - Publications

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Neuropharmacology, dopamine, alcohol
Website:
http://www.med.unc.edu/alcohol/breese.html

277 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Harper KM, Knapp DJ, Todd CA, Balan I, Aurelian L, Criswell HE, Breese GR. Phenotyping CCL2 Containing Central Amygdala Neurons Controlling Alcohol Withdrawal-Induced Anxiety. Frontiers in Cellular Neuroscience. 14: 580583. PMID 33192326 DOI: 10.3389/Fncel.2020.580583  0.714
2019 Harper KM, Knapp DJ, Butler RK, Cook CA, Criswell HE, Stuber GD, Breese GR. Amygdala arginine vasopressin modulates chronic ethanol withdrawal anxiety-like behavior in the social interaction task. Alcoholism, Clinical and Experimental Research. PMID 31386210 DOI: 10.1111/Acer.14163  0.758
2018 Harper KM, Knapp DJ, Criswell HE, Breese GR. Vasopressin and alcohol: a multifaceted relationship. Psychopharmacology. PMID 30392132 DOI: 10.1007/S00213-018-5099-X  0.674
2018 Knapp DJ, Harper KM, Melton J, Breese G. Comparative effects of stressors on behavioral and neuroimmune responses of fawn-hooded (FH/Wjd) and Wistar rats: Implications for models of depression. Journal of Neuroimmunology. 322: 74-80. PMID 30049539 DOI: 10.1016/J.Jneuroim.2018.06.015  0.698
2018 Harper KM, Knapp DJ, Park MA, Breese GR. Differential effects of single versus repeated minocycline administration-Lack of significant interaction with chronic alcohol history. Pharmacology, Biochemistry, and Behavior. PMID 29572015 DOI: 10.1016/J.Pbb.2018.03.007  0.727
2017 Harper KM, Knapp DJ, Park MA, Breese GR. Age related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal Alcohol. 60: 231. DOI: 10.1016/J.Alcohol.2017.02.303  0.674
2016 Butler RK, Knapp DJ, Ulici V, Longobardi L, Loeser RF, Breese GR. A mouse model for chronic pain-induced increase in ethanol consumption. Pain. PMID 27918314 DOI: 10.1097/J.Pain.0000000000000780  0.683
2016 Harper KM, Knapp DJ, Park MA, Breese GR. Age-related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal in male Wistar rats. Psychopharmacology. PMID 27665607 DOI: 10.1007/S00213-016-4439-Y  0.694
2016 Knapp DJ, Harper KM, Whitman BA, Zimomra Z, Breese GR. Stress and Withdrawal from Chronic Ethanol Induce Selective Changes in Neuroimmune mRNAs in Differing Brain Sites. Brain Sciences. 6. PMID 27472367 DOI: 10.3390/Brainsci6030025  0.802
2016 Breese GR, Knapp DJ. Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF. Alcohol (Fayetteville, N.Y.). 52: 9-23. PMID 27139233 DOI: 10.1016/J.Alcohol.2016.01.005  0.696
2016 Knapp DJ, Breese GR. The Use of Perinatal 6-Hydroxydopamine to Produce a Rodent Model of Lesch-Nyhan Disease. Current Topics in Behavioral Neurosciences. PMID 27029809 DOI: 10.1007/7854_2016_444  0.647
2015 Harper KM, Knapp DJ, Breese GR. Withdrawal from Chronic Alcohol Induces a Unique CCL2 mRNA Increase in Adolescent But Not Adult Brain-Relationship to Blood Alcohol Levels and Seizures. Alcoholism, Clinical and Experimental Research. PMID 26556523 DOI: 10.1111/Acer.12898  0.699
2013 Whitman BA, Knapp DJ, Werner DF, Crews FT, Breese GR. The cytokine mRNA increase induced by withdrawal from chronic ethanol in the sterile environment of brain is mediated by CRF and HMGB1 release. Alcoholism, Clinical and Experimental Research. 37: 2086-97. PMID 23895427 DOI: 10.1111/Acer.12189  0.787
2013 Ming Z, Criswell HE, Breese GR. Evidence for TNFα action on excitatory and inhibitory neurotransmission in the central amygdala: a brain site influenced by stress. Brain, Behavior, and Immunity. 33: 102-11. PMID 23770090 DOI: 10.1016/J.Bbi.2013.06.001  0.368
2012 Knapp DJ, Breese GR. Models of chronic alcohol exposure and dependence. Methods in Molecular Biology (Clifton, N.J.). 829: 205-30. PMID 22231816 DOI: 10.1007/978-1-61779-458-2_13  0.701
2012 Hayes DM, Fee JR, McCown TJ, Knapp DJ, Breese GR, Cubero I, Carvajal F, Lerma-Cabrera JM, Navarro M, Thiele TE. Neuropeptide Y signaling modulates the expression of ethanol-induced behavioral sensitization in mice. Addiction Biology. 17: 338-50. PMID 21762289 DOI: 10.1111/J.1369-1600.2011.00336.X  0.739
2011 Knapp DJ, Overstreet DH, Huang M, Wills TA, Whitman BA, Angel RA, Sinnett SE, Breese GR. Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats. Psychopharmacology. 218: 179-89. PMID 21643675 DOI: 10.1007/S00213-011-2366-5  0.832
2011 Knapp DJ, Whitman BA, Wills TA, Angel RA, Overstreet DH, Criswell HE, Ming Z, Breese GR. Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain, Behavior, and Immunity. 25: S146-54. PMID 21377524 DOI: 10.1016/J.Bbi.2011.02.018  0.815
2011 Kelm MK, Criswell HE, Breese GR. Ethanol-enhanced GABA release: a focus on G protein-coupled receptors. Brain Research Reviews. 65: 113-23. PMID 20837058 DOI: 10.1016/J.Brainresrev.2010.09.003  0.823
2010 Wills TA, Knapp DJ, Overstreet DH, Breese GR. Interactions of stress and CRF in ethanol-withdrawal induced anxiety in adolescent and adult rats. Alcoholism, Clinical and Experimental Research. 34: 1603-12. PMID 20586753 DOI: 10.1111/J.1530-0277.2010.01245.X  0.812
2010 Kelm MK, Weinberg RJ, Criswell HE, Breese GR. The PLC/IP 3 R/PKC pathway is required for ethanol-enhanced GABA release. Neuropharmacology. 58: 1179-86. PMID 20206640 DOI: 10.1016/J.Neuropharm.2010.02.018  0.821
2010 Overstreet DH, Fredericks K, Knapp D, Breese G, McMichael J. Nerve growth factor (NGF) has novel antidepressant-like properties in rats Pharmacology Biochemistry and Behavior. 94: 553-560. PMID 19945476 DOI: 10.1016/J.Pbb.2009.11.010  0.7
2010 Huang MM, Overstreet DH, Knapp DJ, Angel R, Wills TA, Navarro M, Rivier J, Vale W, Breese GR. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. The Journal of Pharmacology and Experimental Therapeutics. 332: 298-307. PMID 19843974 DOI: 10.1124/Jpet.109.159186  0.83
2009 Overstreet DH, Knapp DJ, Breese GR, Diamond I. A selective ALDH-2 inhibitor reduces anxiety in rats. Pharmacology, Biochemistry, and Behavior. 94: 255-61. PMID 19747934 DOI: 10.1016/J.Pbb.2009.09.004  0.727
2009 Wills TA, Knapp DJ, Overstreet DH, Breese GR. Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats. Alcoholism, Clinical and Experimental Research. 33: 455-63. PMID 19120055 DOI: 10.1111/J.1530-0277.2008.00856.X  0.796
2009 Sparta DR, Ferraro FM, Fee JR, Knapp DJ, Breese GR, Thiele TE. The alcohol deprivation effect in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. Alcoholism, Clinical and Experimental Research. 33: 31-42. PMID 18945225 DOI: 10.1111/J.1530-0277.2008.00808.X  0.735
2008 Kelm MK, Criswell HE, Breese GR. The role of protein kinase A in the ethanol-induced increase in spontaneous GABA release onto cerebellar Purkinje neurons. Journal of Neurophysiology. 100: 3417-28. PMID 18945815 DOI: 10.1152/Jn.90970.2008  0.818
2008 Papadeas ST, Halloran C, McCown TJ, Breese GR, Blake BL. Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D1 receptor agonist sensitization. The Journal of Comparative Neurology. 511: 271-85. PMID 18785628 DOI: 10.1002/Cne.21835  0.798
2008 Wills TA, Knapp DJ, Overstreet DH, Breese GR. Differential dietary ethanol intake and blood ethanol levels in adolescent and adult rats: effects on anxiety-like behavior and seizure thresholds. Alcoholism, Clinical and Experimental Research. 32: 1350-60. PMID 18540921 DOI: 10.1111/J.1530-0277.2008.00709.X  0.806
2008 Criswell HE, Ming Z, Kelm MK, Breese GR. Brain regional differences in the effect of ethanol on GABA release from presynaptic terminals. The Journal of Pharmacology and Experimental Therapeutics. 326: 596-603. PMID 18502983 DOI: 10.1124/Jpet.107.135418  0.82
2008 Lowery EG, Sparrow AM, Breese GR, Knapp DJ, Thiele TE. The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcoholism, Clinical and Experimental Research. 32: 240-8. PMID 18162074 DOI: 10.1111/J.1530-0277.2007.00573.X  0.749
2008 Navarro M, Cubero I, Knapp DJ, Breese GR, Thiele TE. Decreased immunoreactivity of the melanocortin neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) after chronic ethanol exposure in Sprague-Dawley rats. Alcoholism, Clinical and Experimental Research. 32: 266-76. PMID 18162070 DOI: 10.1111/J.1530-0277.2007.00578.X  0.76
2008 Breese GR, Knapp DJ, Overstreet DH, Navarro M, Wills TA, Angel RA. Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 867-76. PMID 17551540 DOI: 10.1038/Sj.Npp.1301468  0.816
2008 Breese GR, Knapp DJ, Overstreet DH, Navarro M, Wills TA, Angel RA. Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior (Neuropsychopharmacology (2008) 33, (867-876) DOI: 10.1038/sj.npp.1301468) Neuropsychopharmacology. 33: 1777. DOI: 10.1038/Sj.Npp.1301514  0.796
2007 Knapp DJ, Overstreet DH, Angel RA, Navarro M, Breese GR. The amygdala regulates the antianxiety sensitization effect of flumazenil during repeated chronic ethanol or repeated stress. Alcoholism, Clinical and Experimental Research. 31: 1872-82. PMID 17908266 DOI: 10.1111/J.1530-0277.2007.00514.X  0.785
2007 Kelm MK, Criswell HE, Breese GR. Calcium release from presynaptic internal stores is required for ethanol to increase spontaneous gamma-aminobutyric acid release onto cerebellum Purkinje neurons. The Journal of Pharmacology and Experimental Therapeutics. 323: 356-64. PMID 17652632 DOI: 10.1124/Jpet.107.126144  0.817
2007 Overstreet DH, Knapp DJ, Breese GR. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats. Alcoholism, Clinical and Experimental Research. 31: 1473-81. PMID 17624999 DOI: 10.1111/J.1530-0277.2007.00445.X  0.737
2007 Sparta DR, Fee JR, Knapp DJ, Breese GR, Thiele TE. Elevated anxiety-like behavior following ethanol exposure in mutant mice lacking neuropeptide Y (NPY). Drug and Alcohol Dependence. 90: 297-300. PMID 17482381 DOI: 10.1016/J.Drugalcdep.2007.04.001  0.748
2007 Knapp DJ, Overstreet DH, Breese GR. Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal. Alcoholism, Clinical and Experimental Research. 31: 582-95. PMID 17374037 DOI: 10.1111/J.1530-0277.2007.00342.X  0.767
2007 Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 55: 453-62. PMID 17203472 DOI: 10.1002/Glia.20467  0.724
2006 Ming Z, Criswell HE, Yu G, Breese GR. Competing presynaptic and postsynaptic effects of ethanol on cerebellar purkinje neurons. Alcoholism, Clinical and Experimental Research. 30: 1400-7. PMID 16899043 DOI: 10.1111/J.1530-0277.2006.00167.X  0.423
2006 Overstreet DH, Knapp DJ, Angel RA, Navarro M, Breese GR. Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands. Psychopharmacology. 187: 1-12. PMID 16767411 DOI: 10.1007/S00213-006-0389-0  0.77
2006 Ferraro FM, Sparta DR, Knapp DJ, Breese GR, Thiele TE. Increased consumption but not operant self-administration of ethanol in mice lacking the RIIbeta subunit of protein kinase A. Alcoholism, Clinical and Experimental Research. 30: 825-35. PMID 16634851 DOI: 10.1111/J.1530-0277.2006.00096.X  0.741
2006 Breese GR, Criswell HE, Carta M, Dodson PD, Hanchar HJ, Khisti RT, Mameli M, Ming Z, Morrow AL, Olsen RW, Otis TS, Parsons LH, Penland SN, Roberto M, Siggins GR, et al. Basis of the gabamimetic profile of ethanol. Alcoholism, Clinical and Experimental Research. 30: 731-44. PMID 16573592 DOI: 10.1111/J.0145-6008.2006.00086.X  0.622
2006 Fee JR, Knapp DJ, Sparta DR, Breese GR, Picker MJ, Thiele TE. Involvement of protein kinase A in ethanol-induced locomotor activity and sensitization. Neuroscience. 140: 21-31. PMID 16529875 DOI: 10.1016/J.Neuroscience.2006.02.002  0.754
2005 Rodd ZA, Anstrom KK, Knapp DJ, Racz I, Zimmer A, Serra S, Bell RL, Woodward DJ, Breese GR, Colombo G. Factors mediating alcohol craving and relapse: stress, compulsivity, and genetics. Alcoholism, Clinical and Experimental Research. 29: 1325-33. PMID 16088996 DOI: 10.1097/01.Alc.0000171487.62079.A3  0.727
2005 Navarro M, Cubero I, Chen AS, Chen HY, Knapp DJ, Breese GR, Marsh DJ, Thiele TE. Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor. Alcoholism, Clinical and Experimental Research. 29: 949-57. PMID 15976520 DOI: 10.1097/01.Alc.0000167740.19702.8C  0.76
2005 Hayes DM, Knapp DJ, Breese GR, Thiele TE. Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains. Alcoholism, Clinical and Experimental Research. 29: 721-9. PMID 15897715 DOI: 10.1097/01.Alc.0000164375.16838.F3  0.742
2005 Overstreet DH, Knapp DJ, Breese GR. Pharmacological modulation of repeated ethanol withdrawal-induced anxiety-like behavior differs in alcohol-preferring P and Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 81: 122-30. PMID 15894069 DOI: 10.1016/J.Pbb.2005.03.006  0.771
2005 Criswell HE, Breese GR. A conceptualization of integrated actions of ethanol contributing to its GABAmimetic profile: a commentary. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1407-25. PMID 15856077 DOI: 10.1038/Sj.Npp.1300750  0.418
2005 Knapp DJ, Overstreet DH, Breese GR. Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands. Alcoholism, Clinical and Experimental Research. 29: 553-63. PMID 15834220 DOI: 10.1097/01.Alc.0000158840.07475.97  0.772
2005 Breese GR, Overstreet DH, Knapp DJ. Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis. Psychopharmacology. 178: 367-80. PMID 15765253 DOI: 10.1007/S00213-004-2016-2  0.709
2005 Kralic JE, Criswell HE, Osterman JL, O'Buckley TK, Wilkie ME, Matthews DB, Hamre K, Breese GR, Homanics GE, Morrow AL. Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. The Journal of Clinical Investigation. 115: 774-9. PMID 15765150 DOI: 10.1172/Jci23625  0.546
2005 Breese GR, Overstreet DH, Knapp DJ, Navarro M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1662-9. PMID 15726114 DOI: 10.1038/Sj.Npp.1300706  0.757
2005 Breese GR, Chu K, Dayas CV, Funk D, Knapp DJ, Koob GF, Lê DA, O'Dell LE, Overstreet DH, Roberts AJ, Sinha R, Valdez GR, Weiss F. Stress enhancement of craving during sobriety: a risk for relapse. Alcoholism, Clinical and Experimental Research. 29: 185-95. PMID 15714042 DOI: 10.1097/01.Alc.0000153544.83656.3C  0.719
2005 Breese GR, Knapp DJ, Criswell HE, Moy SS, Papadeas ST, Blake BL. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Research. Brain Research Reviews. 48: 57-73. PMID 15708628 DOI: 10.1016/J.Brainresrev.2004.08.004  0.788
2005 Overstreet DH, Knapp DJ, Breese GR. Can CRF1 receptor antagonists become antidepressant and/or anxiolytic agents? Drug Development Research. 65: 191-204. DOI: 10.1002/Ddr.20023  0.734
2004 Fee JR, Sparta DR, Knapp DJ, Breese GR, Picker MJ, Thiele TE. Predictors of high ethanol consumption in RIIbeta knock-out mice: assessment of anxiety and ethanol-induced sedation. Alcoholism, Clinical and Experimental Research. 28: 1459-68. PMID 15597077 DOI: 10.1097/01.Alc.0000141809.53115.71  0.744
2004 Overstreet DH, Knapp DJ, Breese GR. Similar anxiety-like responses in male and female rats exposed to repeated withdrawals from ethanol. Pharmacology, Biochemistry, and Behavior. 78: 459-64. PMID 15251254 DOI: 10.1016/J.Pbb.2004.04.018  0.755
2004 Papadeas ST, Blake BL, Knapp DJ, Breese GR. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5863-76. PMID 15229233 DOI: 10.1523/Jneurosci.0528-04.2004  0.786
2004 Criswell HE, Ming Z, Pleasant N, Griffith BL, Mueller RA, Breese GR. Macrokinetic analysis of blockade of NMDA-gated currents by substituted alcohols, alkanes and ethers. Brain Research. 1015: 107-13. PMID 15223373 DOI: 10.1016/J.Brainres.2004.04.050  0.317
2004 Knapp DJ, Overstreet DH, Moy SS, Breese GR. SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol (Fayetteville, N.Y.). 32: 101-11. PMID 15163561 DOI: 10.1016/J.Alcohol.2003.08.007  0.808
2004 Moy SS, Fernandes A, Qian Y, Rotella DJ, Kostrewa RM, Breese GR. Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss. Pharmacology, Biochemistry, and Behavior. 78: 47-56. PMID 15159133 DOI: 10.1016/J.Pbb.2004.02.013  0.617
2004 Overstreet DH, Knapp DJ, Breese GR. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacology, Biochemistry, and Behavior. 77: 405-13. PMID 14751471 DOI: 10.1016/J.Pbb.2003.11.010  0.779
2004 Breese GR, Knapp DJ, Overstreet DH. Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 470-82. PMID 12955093 DOI: 10.1038/Sj.Npp.1300282  0.767
2004 Knapp DJ, Overstreet DH, Breese GR. PHARMACOLOGICAL REVERSAL OF CYCLED WITHDRAWAL- OR STRESS-SENSITIZED WITHRAWAL ANXIETY AND ENHANCED ETHANOL DRINKING. Alcoholism: Clinical & Experimental Research. 28: 74A. DOI: 10.1097/00000374-200408002-00403  0.748
2004 Knapp DJ, Overstreet DH, Breese GR. SELECTIVE PROPHYLACTIC EFFECT OF ACAMPROSATE AND BACLOFEN IN COUNTERACTING ANXIETY AFTER MULTIPLE ETHANOL WITHDRAWALS. Alcoholism: Clinical & Experimental Research. 28: 42A. DOI: 10.1097/00000374-200408002-00211  0.744
2004 Breese GR, Knapp DJ, Overstreet DH. Erratum: Stress sensitization of ethanol withdrawal-induced reduction in social interaction: Inhibition by CRF-I and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist (Neuropsychopharmacology (2003) 29 (470-482)) Neuropsychopharmacology. 29. DOI: 10.1038/Sj.Npp.1300419  0.74
2004 Overstreet D, Knapp D, Breese G. P.5.039 Acamprosate counteracts anxiety-like behaviorinduced by multiple ethanol withdrawals European Neuropsychopharmacology. 14: S354. DOI: 10.1016/S0924-977X(04)80499-1  0.718
2004 Papadeas S, Breese GR, McCown TJ. 50. AAV-Mediated Expression and Secretion of ADNF-9 Protects Substantia Nigra Neurons from 6-OHDA Damage Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.05.073  0.786
2003 Overstreet DH, Knapp DJ, Moy SS, Breese GR. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Psychopharmacology. 167: 344-52. PMID 12677355 DOI: 10.1007/S00213-003-1425-Y  0.794
2003 Criswell HE, Ming Z, Griffith BL, Breese GR. Comparison of effect of ethanol on N-methyl-D-aspartate- and GABA-gated currents from acutely dissociated neurons: absence of regional differences in sensitivity to ethanol. The Journal of Pharmacology and Experimental Therapeutics. 304: 192-9. PMID 12490591 DOI: 10.1124/Jpet.102.041590  0.458
2002 Breese GR, Knapp DJ, Moy SS. Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neuroscience and Biobehavioral Reviews. 26: 441-55. PMID 12204191 DOI: 10.1016/S0149-7634(02)00011-8  0.764
2002 Overstreet DH, Knapp DJ, Breese GR. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcoholism, Clinical and Experimental Research. 26: 1259-68. PMID 12198403 DOI: 10.1111/J.1530-0277.2002.Tb02665.X  0.758
2002 Moy SS, Breese GR. Phencyclidine supersensitivity in rats with neonatal dopamine loss. Psychopharmacology. 161: 255-62. PMID 12021828 DOI: 10.1007/S00213-002-1017-2  0.607
2002 Visser JE, Smith DW, Moy SS, Breese GR, Friedmann T, Rothstein JD, Jinnah HA. Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. Brain Research. Developmental Brain Research. 133: 127-39. PMID 11882343 DOI: 10.1016/S0165-3806(02)00280-8  0.542
2001 Ming Z, Knapp DJ, Mueller RA, Breese GR, Criswell HE. Differential modulation of GABA- and NMDA-gated currents by ethanol and isoflurane in cultured rat cerebral cortical neurons. Brain Research. 920: 117-24. PMID 11716817 DOI: 10.1016/S0006-8993(01)03044-X  0.736
2001 Knapp DJ, Braun CJ, Duncan GE, Qian Y, Fernandes A, Crews FT, Breese GR. Regional specificity of ethanol and NMDA action in brain revealed with FOS-like immunohistochemistry and differential routes of drug administration. Alcoholism, Clinical and Experimental Research. 25: 1662-72. PMID 11707641 DOI: 10.1111/J.1530-0277.2001.Tb02173.X  0.774
2001 Moy SS, Knapp DJ, Breese GR. Effect of olanzapine on functional responses from sensitized D1-dopamine receptors in rats with neonatal dopamine loss. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 224-33. PMID 11425506 DOI: 10.1016/S0893-133X(01)00224-X  0.777
2000 Knapp DJ, Sim-Selley LJ, Breese GR, Overstreet DH. Selective breeding of 5-HT(1A) receptor-mediated responses: application to emotion and receptor action. Pharmacology, Biochemistry, and Behavior. 67: 701-8. PMID 11166060 DOI: 10.1016/S0091-3057(00)00415-9  0.695
2000 Moy SS, Knapp DJ, Duncan GE, Breese GR. Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal: effects of flumazenil. Psychopharmacology. 152: 208-15. PMID 11057525 DOI: 10.1007/S002130000507  0.823
2000 Yang X, Criswell HE, Breese GR. Ethanol Modulation of γ‐Aminobutyric Acid (GABA)‐Mediated Inhibition of Cerebellar Purkinje Neurons: Relationship to GABAb Receptor Input Alcoholism: Clinical and Experimental Research. 24: 682-690. DOI: 10.1111/J.1530-0277.2000.Tb02040.X  0.406
1999 Yang X, Criswell HE, Breese GR. Action of ethanol on responses to nicotine from cerebellar Purkinje neurons: relationship to methyllycaconitine (MLA) inhibition of nicotine responses. Neurochemistry International. 35: 185-94. PMID 10406002 DOI: 10.1016/S0197-0186(99)00060-1  0.395
1999 Yang X, Criswell HE, Breese GR. Action of ethanol on responses to nicotine from cerebellar interneurons and medial septal neurons: relationship to methyllycaconitine inhibition of nicotine responses. Alcoholism, Clinical and Experimental Research. 23: 983-90. PMID 10397282 DOI: 10.1111/J.1530-0277.1999.Tb04216.X  0.401
1998 Yang X, Knapp DJ, Criswell HE, Breese GR. Action of ethanol and zolpidem on gamma-aminobutyric acid responses from cerebellar Purkinje neurons: relationship to beta-adrenergic receptor input. Alcoholism, Clinical and Experimental Research. 22: 1655-61. PMID 9835278 DOI: 10.1111/J.1530-0277.1998.Tb03963.X  0.731
1998 Moy SS, Duncan GE, Knapp DJ, Breese GR. Sensitivity to ethanol across development in rats: comparison to [3H]zolpidem binding. Alcoholism, Clinical and Experimental Research. 22: 1485-92. PMID 9802533 DOI: 10.1111/J.1530-0277.1998.Tb03940.X  0.795
1998 Duncan GE, Knapp DJ, Breese GR, Crews FT, Little KY. Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain. Pharmacology, Biochemistry, and Behavior. 60: 439-48. PMID 9632227 DOI: 10.1016/S0091-3057(98)00018-5  0.752
1998 Knapp DJ, Duncan GE, Crews FT, Breese GR. Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. Alcoholism, Clinical and Experimental Research. 22: 481-93. PMID 9581657 DOI: 10.1111/J.1530-0277.1998.Tb03677.X  0.808
1998 Duncan GE, Knapp DJ, Carson SW, Breese GR. Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. The Journal of Pharmacology and Experimental Therapeutics. 285: 579-87. PMID 9580601  0.685
1998 Duncan GE, Moy SS, Knapp DJ, Mueller RA, Breese GR. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Research. 787: 181-90. PMID 9518601 DOI: 10.1016/S0006-8993(97)01390-5  0.758
1997 Criswell HE, McCown TJ, Moy SS, Oxford GS, Mueller RA, Morrow AL, Breese GR. Action of zolpidem on responses to GABA in relation to mRNAs for GABA(A) receptor alpha subunits within single cells: evidence for multiple functional GABA(A) isoreceptors on individual neurons. Neuropharmacology. 36: 1641-52. PMID 9517435 DOI: 10.1016/S0028-3908(97)00169-X  0.648
1997 Knapp DJ, Kampov-Polevoy AB, Overstreet DH, Breese GR, Rezvani AH. Ultrasonic vocalization behavior differs between lines of ethanol-preferring and nonpreferring rats. Alcoholism, Clinical and Experimental Research. 21: 1232-40. PMID 9347084 DOI: 10.1111/J.1530-0277.1997.Tb04443.X  0.755
1997 Moy SS, Knapp DJ, Criswell HE, Breese GR. Flumazenil blockade of anxiety following ethanol withdrawal in rats. Psychopharmacology. 131: 354-60. PMID 9226737 DOI: 10.1007/S002130050303  0.822
1997 Moy SS, Criswell HE, Breese GR. Differential effects of bilateral dopamine depletion in neonatal and adult rats. Neuroscience and Biobehavioral Reviews. 21: 425-35. PMID 9195600 DOI: 10.1016/S0149-7634(96)00040-1  0.582
1997 Xiao X, McCown TJ, Li J, Breese GR, Morrow AL, Samulski RJ. Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABA(A) alpha1 containing receptors and increases inferior collicular seizure sensitivity. Brain Research. 756: 76-83. PMID 9187316 DOI: 10.1016/S0006-8993(97)00120-0  0.495
1996 Crews FT, Morrow AL, Criswell H, Breese G. Effects of ethanol on ion channels. International Review of Neurobiology. 39: 283-367. PMID 8894851 DOI: 10.1016/S0074-7742(08)60670-4  0.659
1996 Yang X, Criswell HE, Simson P, Moy S, Breese GR. Evidence for a selective effect of ethanol on N-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitive N-methyl-d-aspartate receptors. The Journal of Pharmacology and Experimental Therapeutics. 278: 114-24. PMID 8764342  0.606
1996 Duncan GE, Knapp DJ, Breese GR. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Research. 713: 79-91. PMID 8724978 DOI: 10.1016/0006-8993(95)01486-1  0.716
1996 Duncan GE, Knapp DJ, Johnson KB, Breese GR. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity. The Journal of Pharmacology and Experimental Therapeutics. 277: 1076-89. PMID 8627519  0.707
1995 Duncan GE, Breese GR, Criswell HE, McCown TJ, Herbert JS, Devaud LL, Morrow AL. Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain. Neuroscience. 64: 1113-28. PMID 7753379 DOI: 10.1016/0306-4522(94)00433-6  0.51
1995 Criswell HE, Simson PE, Knapp DJ, Devaud LL, McCown TJ, Duncan GE, Morrow AL, Breese GR. Effect of zolpidem on gamma-aminobutyric acid (GABA)-induced inhibition predicts the interaction of ethanol with GABA on individual neurons in several rat brain regions. The Journal of Pharmacology and Experimental Therapeutics. 273: 526-36. PMID 7714808  0.768
1995 Devaud LL, Morrow AL, Criswell HE, Breese GR, Duncan GE. Regional differences in the effects of chronic ethanol administration on [3H]zolpidem binding in rat brain. Alcoholism, Clinical and Experimental Research. 19: 910-4. PMID 7485838 DOI: 10.1111/J.1530-0277.1995.Tb00966.X  0.59
1995 Breese GR, Criswell HE, Duncan GE, Moy SS, Johnson KB, Wong DF, Mueller RA. Model for reduced brain dopamine in Lesch-Nyhan syndrome and the mentally retarded: Neurobiology of neonatal-6-hydroxydopamine-lesioned rats Mental Retardation and Developmental Disabilities Research Reviews. 1: 111-119. DOI: 10.1002/Mrdd.1410010207  0.608
1994 Moy SS, Breese GR, Eckerman DA. Altered activity patterns following neonatal 6-hydroxydopamine lesions to dopaminergic neurons: effect of SKF-38393. Brain Research. 645: 49-60. PMID 8062100 DOI: 10.1016/0006-8993(94)91637-3  0.587
1994 Duncan GE, Knapp DJ, Little KY, Breese GR. Neuroanatomical specificity and dose dependence in the time course of imipramine-induced beta adrenergic receptor down-regulation in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 271: 1699-704. PMID 7996487  0.672
1994 Criswell HE, Overstreet DH, Rezvani AH, Johnson KB, Simson PE, Knapp DJ, Moy SS, Breese GR. Effects of ethanol, MK-801, and chlordiazepoxide on locomotor activity in different rat lines: dissociation of locomotor stimulation from ethanol preference. Alcoholism, Clinical and Experimental Research. 18: 917-23. PMID 7978104 DOI: 10.1111/J.1530-0277.1994.Tb00060.X  0.805
1994 Criswell HE, Knapp DJ, Overstreet DH, Breese GR. Effects of ethanol, chlordiazepoxide, and MK-801 on performance in the elevated-plus maze and on locomotor activity. Alcoholism, Clinical and Experimental Research. 18: 596-601. PMID 7943661 DOI: 10.1111/J.1530-0277.1994.Tb00916.X  0.764
1994 Skutella T, Criswell H, Moy S, Probst JC, Breese GR, Jirikowski GF, Holsboer F. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat. Neuroreport. 5: 2181-5. PMID 7865772 DOI: 10.1097/00001756-199410270-00048  0.606
1994 Schambra UB, Duncan GE, Breese GR, Fornaretto MG, Caron MG, Fremeau RT. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience. 62: 65-85. PMID 7816213 DOI: 10.1016/0306-4522(94)90315-8  0.337
1993 Simson PE, Criswell HE, Breese GR. Inhibition of NMDA-evoked electrophysiological activity by ethanol in selected brain regions: evidence for ethanol-sensitive and ethanol-insensitive NMDA-evoked responses. Brain Research. 607: 9-16. PMID 8481813 DOI: 10.1016/0006-8993(93)91483-9  0.433
1993 Duncan GE, Breese GR, Criswell HE, Johnson KB, Schambra UB, Mueller RA, Caron MG, Fremeau RT. D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development. Journal of Neurochemistry. 61: 1255-62. PMID 8376983 DOI: 10.1111/J.1471-4159.1993.Tb13616.X  0.366
1993 Duncan GE, Johnson KB, Breese GR. Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 3932-43. PMID 8366353 DOI: 10.1523/Jneurosci.13-09-03932.1993  0.357
1993 Criswell HE, Breese GR. Similar effects of ethanol and flumazenil on acquisition of a shuttle-box avoidance response during withdrawal from chronic ethanol treatment. British Journal of Pharmacology. 110: 753-60. PMID 8242248 DOI: 10.1111/J.1476-5381.1993.Tb13876.X  0.476
1993 Criswell HE, Simson PE, Duncan GE, McCown TJ, Herbert JS, Morrow AL, Breese GR. Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels. The Journal of Pharmacology and Experimental Therapeutics. 267: 522-37. PMID 8229784  0.557
1993 Duncan GE, Paul IA, Breese GR. Neuroanatomical differences in the rate of beta-adrenergic receptor adaptation after repeated treatment with imipramine. Psychopharmacology Bulletin. 29: 401-7. PMID 8121968  0.567
1993 McCown TJ, Breese GR. A potential contribution to ethanol withdrawal kindling: reduced GABA function in the inferior collicular cortex. Alcoholism, Clinical and Experimental Research. 17: 1290-4. PMID 8116844 DOI: 10.1111/J.1530-0277.1993.Tb05243.X  0.425
1993 Breese GR, Morrow AL, Simson PE, Criswell HE, McCown TJ, Duncan GE, Keir WJ. The neuroanatomical specificity of ethanol action on ligand-gated ion channels: a hypothesis. Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement. 2: 309-13. PMID 7538301  0.537
1992 McCown TJ, Breese GR. The developmental profile of seizure genesis in the inferior collicular cortex of the rat: relevance to human neonatal seizures. Epilepsia. 33: 2-10. PMID 1733756 DOI: 10.1111/J.1528-1157.1992.Tb02275.X  0.315
1992 Duncan GE, Little KY, Kirkman JA, Kaldas RS, Stumpf WE, Breese GR. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns. Brain Research. 591: 181-97. PMID 1332802 DOI: 10.1016/0006-8993(92)91699-F  0.302
1991 Duncan GE, Paul IA, Fassberg JB, Powell KR, Stumpf WE, Breese GR. Autoradiographic analysis of the in vivo distribution of 3H-imipramine and 3H-desipramine in brain: comparison to in vitro binding patterns. Pharmacology, Biochemistry, and Behavior. 38: 621-31. PMID 2068199 DOI: 10.1016/0091-3057(91)90024-V  0.596
1991 McCown TJ, Breese GR. The role of the inferior collicular cortex in the neonatal rat: sensorimotor modulation. Brain Research. Developmental Brain Research. 59: 1-5. PMID 2040074 DOI: 10.1016/0165-3806(91)90022-B  0.339
1991 Simson PE, Criswell HE, Johnson KB, Hicks RE, Breese GR. Ethanol inhibits NMDA-evoked electrophysiological activity in vivo. The Journal of Pharmacology and Experimental Therapeutics. 257: 225-31. PMID 1826926  0.302
1991 Eckerman DA, Moy SS, Perkins AN, Patrick KS, Breese GR. Enantioselective behavioral effects of threo-methylphenidate in rats. Pharmacology, Biochemistry, and Behavior. 40: 875-80. PMID 1816574 DOI: 10.1016/0091-3057(91)90100-G  0.521
1991 Simson PE, Criswell HE, Breese GR. Ethanol potentiates gamma-aminobutyric acid-mediated inhibition in the inferior colliculus: evidence for local ethanol/gamma-aminobutyric acid interactions. The Journal of Pharmacology and Experimental Therapeutics. 259: 1288-93. PMID 1762076  0.313
1991 Sivam SP, Krause JE, Breese GR, Hong JS. Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia. Journal of Neurochemistry. 56: 1499-508. PMID 1707436 DOI: 10.1111/J.1471-4159.1991.Tb02044.X  0.525
1991 Paul IA, Duncan GE, Mueller RA, Hong JS, Breese GR. Neural adaptation in response to chronic imipramine and electroconvulsive shock: evidence for separate mechanisms. European Journal of Pharmacology. 205: 135-43. PMID 1687466 DOI: 10.1016/0014-2999(91)90811-4  0.672
1990 McCown TJ, Breese GR. Multiple withdrawals from chronic ethanol "kindles" inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism. Alcoholism, Clinical and Experimental Research. 14: 394-9. PMID 2378423 DOI: 10.1111/J.1530-0277.1990.Tb00492.X  0.41
1990 Givens BS, Breese GR. Electrophysiological evidence that ethanol alters function of medial septal area without affecting lateral septal function. The Journal of Pharmacology and Experimental Therapeutics. 253: 95-103. PMID 2329526  0.722
1990 Givens BS, Breese GR. Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area. The Journal of Pharmacology and Experimental Therapeutics. 254: 528-38. PMID 2166794  0.717
1990 Criswell HE, Mueller RA, Breese GR. Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist. Brain Research. 512: 284-90. PMID 2162235 DOI: 10.1016/0006-8993(90)90638-R  0.359
1990 Paul IA, Duncan GE, Kuhn C, Mueller RA, Hong JS, Breese GR. Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake. The Journal of Pharmacology and Experimental Therapeutics. 252: 997-1005. PMID 2157002  0.671
1990 Breese GR, Criswell HE, Duncan GE, Mueller RA. A dopamine deficiency model of Lesch-Nyhan disease--the neonatal-6-OHDA-lesioned rat. Brain Research Bulletin. 25: 477-84. PMID 2127238 DOI: 10.1016/0361-9230(90)90240-Z  0.369
1990 Breese GR, Criswell HE, Mueller RA. Evidence that lack of brain dopamine during development can increase the susceptibility for aggression and self-injurious behavior by influencing D1-dopamine receptor function. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 14: S65-80. PMID 1982973 DOI: 10.1016/0278-5846(90)90089-Y  0.326
1989 Duncan GE, Stumpf WE, Breese GR, Mitra KE. Functional activity patterns in the forebrain of swimming rats: a 5 min 2-deoxyglucose study. Neuroscience Letters. 100: 111-6. PMID 2761758 DOI: 10.1016/0304-3940(89)90669-1  0.316
1989 Criswell HE, Breese GR. A conflict procedure not requiring deprivation: evidence that chronic ethanol treatment induces tolerance to the anticonflict action of ethanol and chlordiazepoxide. Alcoholism, Clinical and Experimental Research. 13: 680-5. PMID 2688468 DOI: 10.1111/J.1530-0277.1989.Tb00404.X  0.451
1989 Towle AC, Criswell HE, Maynard EH, Lauder JM, Joh TH, Mueller RA, Breese GR. Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: an anatomical, biochemical and pharmacological study. Pharmacology, Biochemistry, and Behavior. 34: 367-74. PMID 2576138 DOI: 10.1016/0091-3057(89)90328-6  0.343
1989 Sharif NA, Towle AC, Burt DR, Mueller RA, Breese GR. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord. Brain Research. 480: 365-71. PMID 2540880 DOI: 10.1016/0006-8993(89)90209-6  0.306
1989 Duncan GE, Paul IA, Powell KR, Fassberg JB, Stumpf WE, Breese GR. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites. The Journal of Pharmacology and Experimental Therapeutics. 248: 470-7. PMID 2536433  0.554
1989 Criswell H, Mueller RA, Breese GR. Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 125-33. PMID 2521511 DOI: 10.1523/Jneurosci.09-01-00125.1989  0.342
1989 McCown TJ, Breese GR. Mechanistic and functional divergence between thyrotropin-releasing hormone and RO 15-4513 interactions with ethanol. Alcoholism, Clinical and Experimental Research. 13: 660-3. PMID 2512820 DOI: 10.1111/J.1530-0277.1989.Tb00400.X  0.434
1988 Duncan GE, Stumpf WE, Brüstle O, Givens BS, Breese GR, Pilgrim C. Topography of basal glucose utilization in the hippocampus determined with [1-14C]glucose and [6-14C]glucose. Neuroscience. 24: 877-83. PMID 3380305 DOI: 10.1016/0306-4522(88)90074-7  0.618
1988 Paul IA, Duncan GE, Powell KR, Mueller RA, Hong JS, Breese GR. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. The Journal of Pharmacology and Experimental Therapeutics. 246: 956-62. PMID 2843636  0.652
1987 Konkol RJ, Chapman L, Breese GR, Collier AM, Kilts C, Finley C, Vogel RR, Mailman RB, Bendeich EG. Hemophilus influenzae meningitis in the rat: behavioral, electrophysiological, and biochemical consequences. Annals of Neurology. 21: 353-60. PMID 3579220 DOI: 10.1002/Ana.410210407  0.579
1987 Duncan GE, Criswell HE, McCown TJ, Paul IA, Mueller RA, Breese GR. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. The Journal of Pharmacology and Experimental Therapeutics. 243: 1027-34. PMID 3121842  0.605
1987 Hedner J, McCown TJ, Mueller RA, Hedner T, Jonason J, Breese GR. Respiratory stimulant effects by TRH into the mesencephalic region in the rat. Acta Physiologica Scandinavica. 130: 69-75. PMID 3109212 DOI: 10.1111/J.1748-1716.1987.Tb08113.X  0.344
1987 Breese GR, Hulebak KL, Napier TC, Baumeister A, Frye G, Mueller RA. Enhanced muscimol-induced behavioral responses after 6-OHDA lesions: relevance to susceptibility for self-mutilation behavior in neonatally lesioned rats. Psychopharmacology. 91: 356-62. PMID 3104958 DOI: 10.1007/Bf00518191  0.697
1987 McCown TJ, Givens BS, Breese GR. Amino acid influences on seizures elicited within the inferior colliculus. The Journal of Pharmacology and Experimental Therapeutics. 243: 603-8. PMID 2890759  0.605
1987 Sivam SP, Breese GR, Krause JE, Napier TC, Mueller RA, Hong JS. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. Journal of Neurochemistry. 49: 1623-33. PMID 2889804 DOI: 10.1111/J.1471-4159.1987.Tb01036.X  0.508
1986 Frye GD, McCown TJ, Breese GR, Peterson SL. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures. Erratum and additional information. The Journal of Pharmacology and Experimental Therapeutics. 238: 1143. PMID 3598897  0.574
1986 Napier TC, Givens BS, Schulz DW, Bunney BS, Breese GR, Mailman RB. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons. The Journal of Pharmacology and Experimental Therapeutics. 236: 838-45. PMID 3512819  0.744
1986 McCown TJ, Moray LJ, Kizer JS, Breese GR. Interactions between TRH and ethanol in the medial septum. Pharmacology, Biochemistry, and Behavior. 24: 1269-74. PMID 3088607 DOI: 10.1016/0091-3057(86)90183-8  0.477
1986 McCown TJ, Hedner JA, Towle AC, Breese GR, Mueller RA. Brainstem localization of a thyrotropin-releasing hormone-induced change in respiratory function. Brain Research. 373: 189-96. PMID 3087573 DOI: 10.1016/0006-8993(86)90330-6  0.332
1986 Frye GD, McCown TJ, Breese GR, Peterson SL. GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures. The Journal of Pharmacology and Experimental Therapeutics. 237: 478-85. PMID 3009788  0.614
1986 Towle AC, Breese GR, Mueller RA, Hunt R, Lauder JM. Early postnatal administration of 5,7-dihydroxytryptamine: effects on substance P and thyrotropin-releasing hormone neurons and terminals in rat brain. Brain Research. 363: 38-46. PMID 2418913 DOI: 10.1016/0006-8993(86)90656-6  0.328
1986 Breese GR, Creese I. Neurobiology of central D1-dopamine receptors Advances in Experimental Medicine and Biology. 204. DOI: 10.1007/978-1-4684-5191-7  0.306
1985 Coyle S, Napier TC, Breese GR. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures. Brain Research. 355: 27-38. PMID 4075104 DOI: 10.1016/0165-3806(85)90004-5  0.367
1985 Patrick KS, Ellington KR, Breese GR, Kilts CD. Gas chromatographic-mass spectrometric analysis of methylphenidate and p-hydroxymethylphenidate using deuterated internal standards. Journal of Chromatography. 343: 329-38. PMID 4066874 DOI: 10.1016/S0378-4347(00)84601-0  0.49
1985 Napier TC, Coyle S, Breese GR. Ontogeny of striatal unit activity and effects of single or repeated haloperidol administration in rats. Brain Research. 333: 35-44. PMID 4039617 DOI: 10.1016/0006-8993(85)90121-0  0.334
1985 McCown TJ, Frye GD, Breese GR. Evidence for site specific ethanol actions in the CNS. Alcohol and Drug Research. 6: 423-9. PMID 3939188  0.663
1985 Napier TC, Gay DA, Hulebak KL, Breese GR. Behavioral and biochemical assessment of time-related changes in globus pallidus and striatal dopamine induced by intranigrally administered neurotensin. Peptides. 6: 1057-68. PMID 3938838 DOI: 10.1016/0196-9781(85)90428-0  0.367
1985 Breese GR, Baumeister A, Napier TC, Frye GD, Mueller RA. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. The Journal of Pharmacology and Experimental Therapeutics. 235: 287-95. PMID 3932640  0.685
1985 Breese GR, Coyle S, Frye GD, Mueller RA. Effects of TRH, ethanol, and TRH-ethanol combination on activity in rats with altered monoamine content. Pharmacology, Biochemistry, and Behavior. 22: 1013-8. PMID 3927322 DOI: 10.1016/0091-3057(85)90311-9  0.696
1985 Mueller RA, Towle AC, Breese GR. The role of vagal afferents and carbon dioxide in the respiratory response to thyrotropin-releasing hormone. Regulatory Peptides. 10: 157-66. PMID 3922012 DOI: 10.1016/0167-0115(85)90010-2  0.35
1985 Duncan GE, Paul IA, Harden TK, Mueller RA, Stumpf WE, Breese GR. Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation. The Journal of Pharmacology and Experimental Therapeutics. 234: 402-8. PMID 2991500  0.57
1985 Breese GR, Mueller RA. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons. European Journal of Pharmacology. 113: 109-14. PMID 2864260 DOI: 10.1016/0014-2999(85)90349-8  0.348
1985 Mueller RA, Towle A, Breese GR. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine. Pharmacology, Biochemistry, and Behavior. 22: 221-5. PMID 2580321 DOI: 10.1016/0091-3057(85)90381-8  0.352
1985 Towle AC, Mueller RA, Breese GR, Lauder J. Altered respiratory response to substance P in capsaicin-treated rats. Journal of Neuroscience Research. 14: 239-53. PMID 2413226 DOI: 10.1002/Jnr.490140209  0.345
1984 Kilts CD, Knight DL, Mailman RB, Widerlöv E, Breese GR. Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine. The Journal of Pharmacology and Experimental Therapeutics. 231: 334-42. PMID 6491985  0.537
1984 McCown TJ, Greenwood RS, Frye GD, Breese GR. Electrically elicited seizures from the inferior colliculus: a potential site for the genesis of epilepsy? Experimental Neurology. 86: 527-42. PMID 6437856 DOI: 10.1016/0014-4886(84)90087-6  0.555
1984 Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Mueller RA. Neonatal-6-hydroxydopamine treatment: model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome. Pharmacology, Biochemistry, and Behavior. 21: 459-61. PMID 6436840 DOI: 10.1016/S0091-3057(84)80110-0  0.696
1984 Widerlöv E, Mueller RA, Frye GD, Breese GR. Bombesin increases dopamine function in rat brain areas. Peptides. 5: 523-8. PMID 6433330 DOI: 10.1016/0196-9781(84)90081-0  0.623
1984 Breese GR, Frye GD, McCown TJ, Mueller RA. Comparison of the CNS effects induced by TRH and bicuculline after microinjection into medial septum, substantia nigra and inferior colliculus: absence of support for a GABA antagonist action for TRH. Pharmacology, Biochemistry, and Behavior. 21: 145-9. PMID 6431450 DOI: 10.1016/0091-3057(84)90144-8  0.67
1984 Breese GR, Coyle S, Towle AC, Mueller RA, McCown TJ, Frye GD. Ethanol-induced locomotor stimulation in rats after thyrotropin-releasing hormone. The Journal of Pharmacology and Experimental Therapeutics. 229: 731-7. PMID 6427448  0.655
1984 Mueller RA, Towle AC, Breese GR. Supersensitivity to the respiratory stimulatory effect of TRH in 5,7-dihydroxytryptamine-treated rats. Brain Research. 298: 370-3. PMID 6426700 DOI: 10.1016/0006-8993(84)91440-9  0.338
1984 Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. The Journal of Pharmacology and Experimental Therapeutics. 231: 343-54. PMID 6149306  0.684
1983 Nemeroff CB, Luttinger D, Hernandez DE, Mailman RB, Mason GA, Davis SD, Widerlöv E, Frye GD, Kilts CA, Beaumont K, Breese GR, Prange AJ. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. The Journal of Pharmacology and Experimental Therapeutics. 225: 337-45. PMID 6682440  0.692
1983 Wargin W, Patrick K, Kilts C, Gualtieri CT, Ellington K, Mueller RA, Kraemer G, Breese GR. Pharmacokinetics of methylphenidate in man, rat and monkey. The Journal of Pharmacology and Experimental Therapeutics. 226: 382-6. PMID 6410043  0.468
1983 Frye GD, McCown TJ, Breese GR. Characterization of susceptibility to audiogenic seizures in ethanol-dependent rats after microinjection of gamma-aminobutyric acid (GABA) agonists into the inferior colliculus, substantia nigra or medial septum. The Journal of Pharmacology and Experimental Therapeutics. 227: 663-70. PMID 6317842  0.608
1983 Sharif NA, Burt DR, Towle AC, Mueller RA, Breese GR. Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors. European Journal of Pharmacology. 95: 301-4. PMID 6317416 DOI: 10.1016/0014-2999(83)90651-9  0.306
1983 Frye GD, McCown TJ, Breese GR. Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors. The Journal of Pharmacology and Experimental Therapeutics. 226: 720-5. PMID 6310080  0.595
1983 Widerlöv E, Kalivas PW, Lewis MH, Prange AJ, Breese GR. Influence of cholecystokinin on central monoaminergic pathways. Regulatory Peptides. 6: 99-109. PMID 6308717 DOI: 10.1016/0167-0115(83)90003-4  0.369
1982 Chapin RE, Breese GR, Mueller RA. Dopamine antagonists do not block testosterone-induced decrease in luteinizing hormone. Pharmacology, Biochemistry, and Behavior. 17: 681-4. PMID 7178181 DOI: 10.1016/0091-3057(82)90345-8  0.353
1982 Widerlöv E, Häggström JE, Kilts CD, Andersson U, Breese GR, Mailman RB. Serum concentrations of thioridazine, its major metabolites and serum neuroleptic-like activities in schizophrenics with and without tardive dyskinesia. Acta Psychiatrica Scandinavica. 66: 294-305. PMID 7148482 DOI: 10.1111/J.1600-0447.1982.Tb00308.X  0.497
1982 Lundberg D, Mueller RA, Breese GR. Effects of vagotomy and glossopharyngectomy on respiratory response to dopamine-agonists. Acta Physiologica Scandinavica. 114: 81-9. PMID 6814193 DOI: 10.1111/J.1748-1716.1982.Tb06955.X  0.355
1982 Widerlöv E, Kilts CD, Mailman RB, Nemeroff CB, Mc Cown TJ, Prange AJ, Breese GR. Increase in dopamine metabolites in rat brain by neurotensin. The Journal of Pharmacology and Experimental Therapeutics. 223: 1-6. PMID 6811728  0.522
1982 Frye GD, Breese GR. GABAergic modulation of ethanol-induced motor impairment. The Journal of Pharmacology and Experimental Therapeutics. 223: 750-6. PMID 6292399  0.608
1982 Kilts CD, Patrick KS, Breese GR, Mailman RB. Simultaneous determination of thioridazine and its S-oxidized and N-demethylated metabolites using high-performance liquid-chromatography on radially compressed silica. Journal of Chromatography. 231: 377-91. PMID 6290516 DOI: 10.1016/S0378-4347(00)81862-9  0.473
1982 Widerlöv E, Breese GR. ACTIONS OF NEUROTENSIN ON DOPAMINERGIC AND SEROTONERGIC PATHWAYS IN RAT BRAIN Annals of the New York Academy of Sciences. 400: 428-430. DOI: 10.1111/J.1749-6632.1982.Tb31604.X  0.356
1982 Patrick K, Kilts C, Breese G. Synthesis of deuterium-labelled methylphenidate, p-hydroxymethylphenidate, ritalinic acid and p-hydroxyritalinic acid Journal of Labelled Compounds and Radiopharmaceuticals. 19: 485-490. DOI: 10.1002/Jlcr.2580190404  0.481
1982 PATRICK KS, KILTS CD, BREESE GR. ChemInform Abstract: SYNTHESIS AND PHARMACOLOGY OF HYDROXYLATED METABOLITES OF METHYL PHENIDATE Chemischer Informationsdienst. 13. DOI: 10.1002/CHIN.198211217  0.421
1981 Patrick KS, Kilts CD, Breese GR. Synthesis and pharmacology of hydroxylated metabolites of methylphenidate. Journal of Medicinal Chemistry. 24: 1237-40. PMID 7328584 DOI: 10.1021/Jm00142A021  0.493
1981 Kilts CD, Breese GR, Mailman RB. Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection. Journal of Chromatography. 225: 347-57. PMID 7298770 DOI: 10.1016/S0378-4347(00)80283-2  0.501
1981 Frye GD, Chapin RE, Vogel RA, Mailman RB, Kilts CD, Mueller RA, Breese GR. Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanol. The Journal of Pharmacology and Experimental Therapeutics. 216: 306-14. PMID 7193248  0.744
1981 Frye GD, Breese GR. An evaluation of the locomotor stimulating action of ethanol in rats and mice. Psychopharmacology. 75: 372-9. PMID 6803283 DOI: 10.1007/Bf00435856  0.675
1981 Pappas BA, Vogel RA, Wilson JH, Mueller RA, Breese GR. Drug alterations of punished responding after chlordiazepoxide: possible screen for agents useful in minimal brain dysfunction. Pharmacology, Biochemistry, and Behavior. 15: 743-6. PMID 6796972 DOI: 10.1016/0091-3057(81)90016-2  0.321
1981 Vogel RA, Frye GD, Koepke KM, Mailman RB, Mueller RA, Breese GR. Differential effects of TRH, amphetamine, naloxone, and fenmetozole on ethanol actions: attenuation of the effects of punishment and impairment of aerial righting reflex. Alcoholism, Clinical and Experimental Research. 5: 386-92. PMID 6792942 DOI: 10.1111/J.1530-0277.1981.Tb04921.X  0.681
1981 Kuhn CM, Vogel RA, Mailman RB, Mueller RA, Schanberg SM, Breese GR. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats. Psychopharmacology. 73: 188-93. PMID 6785814 DOI: 10.1007/Bf00429216  0.422
1981 Kraemer GW, Breese GR, Prange AJ, Moran EC, Lewis JK, Kemnitz JW, Bushnell PJ, Howard JL, McKinney WT. Use of 6-hydroxydopamine to deplete brain catecholamines in the rhesus monkey: effects on urinary catecholamine metabolites and behavior. Psychopharmacology. 73: 1-11. PMID 6785782 DOI: 10.1007/Bf00431091  0.323
1981 Chapin RE, Breese GR, Mueller RA. Antagonism of ethanol-induced decrease in LH by para-chlorophenylalanine: lack of correlation with altered serotonergic mechanisms. Pharmacology, Biochemistry, and Behavior. 14: 293-8. PMID 6453351 DOI: 10.1016/0091-3057(81)90393-2  0.449
1981 Frye GD, Luttinger D, Nemeroff CB, Vogel RA, Prange AJ, Breese GR. Modification of the actions of ethanol by centrally active peptides. Peptides. 2: 99-106. PMID 6267562 DOI: 10.1016/0196-9781(81)90063-2  0.667
1981 Luttinger D, Nemeroff CB, Mason GA, Frye GD, Breese GR, Prange AJ. Enhancement of ethanol-induced sedation and hypothermia by centrally administered neurotensin, beta-endorphin and bombesin. Neuropharmacology. 20: 305-9. PMID 6267506 DOI: 10.1016/0028-3908(81)90139-8  0.671
1981 Breese GR, Mueller RA, Mailman RB, Frye GD. Effects of TRH on central nervous system function. Progress in Clinical and Biological Research. 68: 99-116. PMID 6117881  0.553
1981 Ondrusek MG, Kilts CD, Frye GD, Mailman RB, Mueller RA, Breese GR. Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity. Psychopharmacology. 73: 17-22. PMID 6112768 DOI: 10.1007/Bf00431093  0.715
1980 Mailman RB, Ferris RM, Tang FL, Vogel RA, Kilts CD, Lipton MA, Smith DA, Mueller RA, Breese GR. Erythrosine (Red No. 3) and its nonspecific biochemical actions: what relation to behavioral changes? Science (New York, N.Y.). 207: 535-7. PMID 7352264 DOI: 10.1126/Science.7352264  0.587
1980 Mueller RA, Lundberg D, Breese GR. Evidence that respiratory depression by serotonin agonists may be exerted in the central nervous system. Pharmacology, Biochemistry, and Behavior. 13: 247-55. PMID 6968074 DOI: 10.1016/0091-3057(80)90081-7  0.343
1980 Mueller RA, Lundberg D, Breese G. Effects of Different Monoamine Oxidase Inhibitors on Respiratory Activity in Rats with Chronically Impaired Central Serotonergic Function Acta Pharmacologica Et Toxicologica. 47: 285-293. PMID 6781223 DOI: 10.1111/J.1600-0773.1980.Tb03656.X  0.345
1980 Vogel RA, Frye GD, Wilson JH, Kuhn CM, Koepke KM, Mailman RB, Mueller RA, Breese GR. Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxide. Psychopharmacology. 71: 123-9. PMID 6777811 DOI: 10.1007/Bf00434399  0.69
1980 Nemeroff CB, Bissette G, Manberg PJ, Osbahr AJ, Breese GR, Prange AJ. Neurotensin-induced hypothermia: evidence for an interaction with dopaminergic systems and the hypothalamic--pituitary--thyroid axis. Brain Research. 195: 69-84. PMID 6446951 DOI: 10.1016/0006-8993(80)90867-7  0.4
1980 Pappas BA, Breese GR, Mailman RB, Mueller RA. Importance of the Locus coeruleus and involvement of alpha-adrenergic receptors in the post-decapitation reflex in the rat. Psychopharmacology. 69: 163-71. PMID 6256789 DOI: 10.1007/Bf00427644  0.332
1980 Frye GD, Breese GR, Mailman RB, Vogel RA, Ondrusek MG, Mueller RA. An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system function. Psychopharmacology. 69: 149-55. PMID 6256788 DOI: 10.1007/Bf00427641  0.69
1980 Frye GD, Vogel RA, Mailman RB, Ondrusek MG, Wilson JH, Mueller PA, Breese GR. A comparison of behavioral and neurochemical effects of ethanol and chlordiazepoxide. Advances in Experimental Medicine and Biology. 132: 729-37. PMID 6252770 DOI: 10.1007/978-1-4757-1419-7_76  0.653
1980 Mailman RB, Frye GD, Mueller RA, Breese GR. The effects of thyrotropin-releasing hormone (TRH) and other drugs on the actions of alcohol. Advances in Experimental Medicine and Biology. 126: 509-22. PMID 6250330 DOI: 10.1007/978-1-4684-3632-7_38  0.67
1980 Vogel RA, Frye GD, Wilson JH, Kuhn CM, Mailman RB, Mueller RA, Breese GR. Attenuation of the effect of punishment by thyrotropin-releasing hormone: comparisons with chlordiazepoxide. The Journal of Pharmacology and Experimental Therapeutics. 212: 153-61. PMID 6243358  0.52
1980 Roger LJ, Breese GR, Morell P. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine. Brain Research. 197: 95-112. PMID 6156743 DOI: 10.1016/0006-8993(80)90437-0  0.308
1980 Nemeroff CB, Luttinger D, Mason GA, Frye GD, Breese GR, Prange AJ. Effects of intracisternal neurotensin, β-endorphin or bombesin on ethanol-induced sedation and hypothermia Drug and Alcohol Dependence. 6: 112-113. DOI: 10.1016/0376-8716(80)90434-2  0.638
1979 Breese GR, Lundberg DB, Mailman RB, Frye GD, Mueller RA. Effect of ethanol on cyclic nucleotides in vivo: consequences of controlling motor and respiratory changes. Drug and Alcohol Dependence. 4: 321-6. PMID 230951 DOI: 10.1016/0376-8716(79)90014-0  0.679
1979 Harden TK, Mailman RB, Mueller RA, Breese GR. Noradrenergic hyperinnervation reduces the density of beta-adrenergic receptors in rat cerebellum. Brain Research. 166: 194-8. PMID 217500 DOI: 10.1016/0006-8993(79)90664-4  0.302
1979 Lundberg DB, Breese GR, Mailman RB, Frye GD, Mueller RA. Depression of some drug-induced in vivo changes of cerebellar guanosine 3',5'-monophosphate by control of motor and respiratory responses. Molecular Pharmacology. 15: 246-56. PMID 38389  0.5
1979 Lundberg D, Breese GR, Mueller RA. Dopaminergic interaction with the respiratory control system in the rat. European Journal of Pharmacology. 54: 153-9. PMID 33815 DOI: 10.1016/0014-2999(79)90417-5  0.337
1979 Mailman RB, Frye GD, Mueller RA, Breese GR. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone. The Journal of Pharmacology and Experimental Therapeutics. 208: 169-75. PMID 33261  0.585
1979 Frye G, Breese G, Mailman R, Vogel R, Mueller R. Similarities in the central actions of GABA-mimetic drugs:. and ethanol Brain Research Bulletin. 4: 706. DOI: 10.1016/0361-9230(79)90244-2  0.631
1978 Mueller RA, Lundberg D, Frye GD, Mailman RB, Breese GR. Cerebellar cGMP varies with motor function and respiratory gas exchange. Neuroscience Letters. 10: 89-93. PMID 19605262 DOI: 10.1016/0304-3940(78)90017-4  0.55
1978 Bendeich E, Konkol RJ, Krigman MR, Breese GR. Morphological evidence for 6-hydroxydopamine-induced sprouting or noradrenergic neurons in the cerebellum. Journal of the Neurological Sciences. 38: 47-57. PMID 702183 DOI: 10.1016/0022-510X(78)90244-7  0.33
1978 Mailman RB, Krigman MR, Mueller RA, Mushak P, Breese GR. Lead exposure during infancy permanently increases lithium-induced polydipsia. Science (New York, N.Y.). 201: 637-9. PMID 675249 DOI: 10.1126/Science.675249  0.33
1978 Konkol RJ, Bendeich EG, Breese GR. A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine. Brain Research. 140: 125-35. PMID 626876 DOI: 10.1016/0006-8993(78)90242-1  0.323
1978 Breese GR, Mueller RA. Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacologic agents in adult and developing rats. Annals of the New York Academy of Sciences. 305: 160-74. PMID 280248 DOI: 10.1111/J.1749-6632.1978.Tb31519.X  0.303
1978 Mailman RB, Mueller RA, Breese GR. The effect of drugs which alter GABA-ergic function on cerebellar guanosine-3',5'-monophosphate content. Life Sciences. 23: 623-7. PMID 211362 DOI: 10.1016/0024-3205(78)90043-7  0.385
1978 Mailman RB, Frye GD, Mueller RA, Breese GR. Thyrotropin-releasing hormone reversal of ethanol-induced decreases in cerebellar cGMP. Nature. 272: 832-3. PMID 205800 DOI: 10.1038/272832A0  0.677
1978 Breese GR, Mailman RB, Ondrusek MG, Harden TK, Mueller RA. Effects of dopaminergic agonists and antagonists on cerebellar guanosine-3',5'-monophosphate (cGMP). Life Sciences. 23: 533-6. PMID 29192 DOI: 10.1016/0024-3205(78)90167-4  0.358
1978 Breese GR, Mueller RA, Mailman RB, Frye GD, Vogel RA. An alternative to animal models of central nervous system disorders: Study of drug mechanisms and disease symptoms in animals Progress in Neuro-Psychopharmacology. 2: 313-325. DOI: 10.1016/0364-7722(78)90089-9  0.55
1977 Nemeroff CB, Konkol RJ, Bissette G, Youngblood W, Martin JB, Brazeau P, Rone MS, Prange AJ, Breese GR, Kizer JS. Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation. Endocrinology. 101: 613-22. PMID 407073 DOI: 10.1210/Endo-101-2-613  0.315
1976 Kraemer GW, Mueller R, Breese GR, Prange AJ, Lewis JK, Morrison H, McKinney WT. Thyrotropin releasing hormone: antagonism of pentobarbital narcosis in the monkey. Pharmacology, Biochemistry, and Behavior. 4: 709-12. PMID 824652 DOI: 10.1016/0091-3057(76)90224-0  0.304
1976 Cott JM, Breese GR, Cooper BR, Barlow S, Prange AJ. Investigations into the mechanism of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH). The Journal of Pharmacology and Experimental Therapeutics. 196: 594-604. PMID 177753  0.712
1975 Breese GR, Cooper BR. Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats. Brain Research. 98: 517-27. PMID 1242372 DOI: 10.1016/0006-8993(75)90370-4  0.39
1975 Hollister AS, Ervin GN, Cooper BR, Breese GR. The roles of monoamine neural systems in the anorexia induced by(+)-amphetamine and related compounds. Neuropharmacology. 14: 715-23. PMID 1196470 DOI: 10.1016/0028-3908(75)90096-9  0.334
1975 Mueller RA, Smith RD, Spruill WA, Breese GR. Central monaminergic neuronal effects on minimum alveolar concentrations (MAC) of halothane and cyclopropane in rats. Anesthesiology. 42: 143-52. PMID 1115362 DOI: 10.1097/00000542-197502000-00006  0.355
1975 Prange AJ, Breese GR, Jahnke GD, Cooper BR, Cott JM, Wilson IC, Lipton MA, Plotnikoff NP. Parameters of alteration of pentobarbital response by hypothalamic polypeptides. Neuropsychobiology. 1: 121-31. PMID 817220 DOI: 10.1159/000117484  0.672
1975 Plotnikoff NP, Breese GR, Prange AJ. Thyrotropin releasing hormone (TRH): DOPA potentiation and biogenic amine studies. Pharmacology, Biochemistry, and Behavior. 3: 665-70. PMID 810812 DOI: 10.1016/0091-3057(75)90189-6  0.339
1975 Breese GR, Cott JM, Cooper BR, Prange AJ, Lipton MA, Plotnikoff NP. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. The Journal of Pharmacology and Experimental Therapeutics. 193: 11-22. PMID 805836  0.651
1975 Prange AJ, Breese GR, Jahnke GD, Martin BR, Cooper BT, Cott JM, Wilson IC, Alltop LB, Lipton MA, Bissette G, Nemeroff CG, Loosen PT. Modification of pentobarbital effects by natural and synthetic polypeptides: dissociation of brain and pituitary effects. Life Sciences. 16: 1907-13. PMID 239299 DOI: 10.1016/0024-3205(75)90284-2  0.652
1975 Breese GR, Cooper BR, Hollister AS. Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate. Psychopharmacologia. 44: 5-10. PMID 128026 DOI: 10.1007/Bf00421175  0.391
1975 Breese GR, Smith RD, Cooper BR. Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior. Pharmacology, Biochemistry, and Behavior. 3: 1097-106. PMID 4816 DOI: 10.1016/0091-3057(75)90023-4  0.346
1975 Prange AJ, Wilson IC, Breese GR, Lipton MA. Behavioral effects of hypothalamic releasing hormones in animals and men. Progress in Brain Research. 42: 1-9. PMID 729 DOI: 10.1016/S0079-6123(08)63636-5  0.312
1975 Prange AJ, Breese GR, Jahnke GD, Martin BR, Cooper BR, Cott JM, Wilson IC, Alltop LB, Lipton MA, Bissette G, Nemeroff CB, Loosen PT. Modification of pentobarbital effects by natural and synthetic polypeptides: Dissociation of brain and pituirary effects Life Sciences. 16: 1907-1913. DOI: 10.1016/0024-3205(75)90300-8  0.648
1974 Breese GR, Cooper BR, Smith RD. BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 6-HYDROXYDOPAMINE ADMINISTRATION INTO BRAIN. Biochemical Pharmacology. 23: 574-579. PMID 21394240 DOI: 10.1016/0024-3205(73)90242-7  0.387
1974 Cooper BR, Cott JM, Breese GR. Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments. Psychopharmacologia. 37: 235-48. PMID 4851731 DOI: 10.1007/Bf00421537  0.71
1974 Cooper BR, Howard JL, Grant LD, Smith RD, Breese GR. Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine. Pharmacology, Biochemistry, and Behavior. 2: 639-49. PMID 4610593 DOI: 10.1016/0091-3057(74)90033-1  0.334
1974 Breese GR, Cooper BR, Grant LD, Smith RD. Biochemical and behavioural alterations following 5,6-dihydroxytryptamine administration into brain. Neuropharmacology. 13: 177-87. PMID 4407423 DOI: 10.1016/0028-3908(74)90105-1  0.368
1974 Prange AJ, Breese GR, Cott JM, Martin BR, Cooper BR, Wilson IC, Plotnikoff NP. Thydrotropin releasing hormone: antagonism of pentobarbital in rodents. Life Sciences. 14: 447-55. PMID 4207373 DOI: 10.1016/0024-3205(74)90359-2  0.672
1974 Plotnikoff NP, Prange AJ, Breese GR, Wilson IC. Thyrotropin releasing hormone: enhancement of DOPA activity in thyroidectomized rats. Life Sciences. 14: 1271-8. PMID 4207315 DOI: 10.1016/0024-3205(74)90435-4  0.354
1974 Breese GR, Cott JM, Cooper BR, Prange AJ, Lipton MA. Antagonism of ethanol narcosis by thyrotropin releasing hormone. Life Sciences. 14: 1053-63. PMID 4207201 DOI: 10.1016/0024-3205(74)90230-6  0.741
1974 Breese GR, Cooper BR, Mueller RA. Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine. British Journal of Pharmacology. 52: 307-314. PMID 4155993 DOI: 10.1111/J.1476-5381.1974.Tb09714.X  0.365
1974 Howard JL, Smith RD, Mueller RA, Breese GR. Cardiovascular changes following DOCA-NaCl or conditioning in 6-hydroxydopamine-treated rats. Pharmacology, Biochemistry, and Behavior. 2: 537-43. PMID 4153826 DOI: 10.1016/0091-3057(74)90015-X  0.313
1974 Hollister AS, Breese GR, Cooper BR. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity. Psychopharmacologia. 36: 1-16. PMID 4151923 DOI: 10.1007/Bf00441377  0.354
1973 Carpenter D, Breese G, Schanberg S, Kopin I. Serotonin and dopamine: distribution and accumulation in Aplysia nervous and non-nervous tissues. The International Journal of Neuroscience. 2: 49-56. PMID 5161303 DOI: 10.3109/00207457109146992  0.447
1973 Breese GR, Smith RD, Cooper BR, Grant LD. Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine. Pharmacology, Biochemistry, and Behavior. 1: 319-28. PMID 4775860 DOI: 10.1016/0091-3057(73)90124-X  0.373
1973 Cooper BR, Grant LD, Breese GR. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments. Psychopharmacologia. 31: 95-109. PMID 4722209 DOI: 10.1007/Bf00419810  0.355
1972 Breese GR, Traylor TD, Prange AJ. The effect of triiodothyronine on the disposition and actions of imipramine. Psychopharmacologia. 25: 101-11. PMID 5048511 DOI: 10.1007/Bf00423187  0.386
1972 Cooper BR, Breese GR, Howard JL, Grant LD. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion. Physiology & Behavior. 9: 727-31. PMID 4655165 DOI: 10.1016/0031-9384(72)90041-8  0.354
1972 Cooper BR, Breese GR, Howard JL, Grant LD. Enhanced behavioral depressant effects of reserpine and -methyltyrosine after 6-hydroxydopamine treatment. Psychopharmacologia. 27: 99-110. PMID 4638213 DOI: 10.1007/Bf00439368  0.351
1972 Breese GR, Prange AJ, Howard JL, Lipton MA, McKinney WT, Bowman RE, Bushnell P. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine. Nature: New Biology. 240: 286-7. PMID 4633263 DOI: 10.1038/Newbio240286A0  0.313
1972 Breese GR, Traylor TD. Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine. British Journal of Pharmacology. 44: 210-22. PMID 4148915 DOI: 10.1111/J.1476-5381.1972.Tb07257.X  0.352
1971 Breese GR, Prange AJ. Chronic dopa treatment: effect on the concentration of norepinephrine in the hearts and brains of rats. European Journal of Pharmacology. 13: 259-61. PMID 5544078 DOI: 10.1016/0014-2999(71)90158-0  0.33
1971 Breese GR, Howard JL. Effect of central catecholamine alterations on the hypothermic response to 6-hydroxydopamine in desipramine treated rats. British Journal of Pharmacology. 43: 671-4. PMID 5157728 DOI: 10.1111/J.1476-5381.1971.Tb07197.X  0.382
1971 Breese GR, Howard JL, Leahy JP. Effect of 6-hydroxydopamine on electrical self stimulation of the brain. British Journal of Pharmacology. 43: 255-7. PMID 5136461 DOI: 10.1111/J.1476-5381.1971.Tb07177.X  0.305
1971 Chase TN, Breese GR, Gordon EK, Kopin IJ. Catecholamine metabolism in the dog: comparison of intravenously and intraventricularly administered [14C]dopamine and [3H]norepinephrine. Journal of Neurochemistry. 18: 135-40. PMID 5107962 DOI: 10.1111/J.1471-4159.1971.Tb00175.X  0.453
1970 Breese GR, Kopin IJ, Weise VK. Effects of amphetamine derivatives on brain dopamine and noradrenaline. British Journal of Pharmacology. 38: 537-45. PMID 4909707 DOI: 10.1111/J.1476-5381.1970.Tb10595.X  0.454
1970 Breese GR, Chase TN, Kopin IJ. Effect of monoamine oxidase inhibitors on the disposition of intracisternally administered metaraminol-3H. Biochemical Pharmacology. 19: 525-32. PMID 4396250 DOI: 10.1016/0006-2952(70)90209-1  0.482
1969 Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ. Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain. Biochemical Pharmacology. 18: 1971-8. PMID 5811629 DOI: 10.1016/0006-2952(69)90293-7  0.51
1969 Breese GR, Chase TN, Kopin IJ. Metabolism of some phenylethylamines and their beta-hydroxylated analogs in brain. The Journal of Pharmacology and Experimental Therapeutics. 165: 9-13. PMID 5782838  0.334
1969 Breese GR, Chase TN, Kopin IJ. Metabolism of tyramine-3H and octopamine-3H by rat brain. Biochemical Pharmacology. 18: 863-9. PMID 4389230 DOI: 10.1016/0006-2952(69)90057-4  0.451
1968 Kopin IJ, Breese GR, Krauss KR, Weise VK. Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. The Journal of Pharmacology and Experimental Therapeutics. 161: 271-8. PMID 5650139  0.329
1968 Schanberg SM, Schildkraut JJ, Breese GR, Kopin IJ. Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochemical Pharmacology. 17: 247-54. PMID 5647052 DOI: 10.1016/0006-2952(68)90330-4  0.475
1968 Schanberg SM, Breese GR, Schildkraut KK, Gordon EK, Kopin IJ. 3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid. Biochemical Pharmacology. 17: 2006-8. PMID 4972145 DOI: 10.1016/0006-2952(68)90119-6  0.42
1968 Chase TN, Breese GR, Carpenter DO, Schanberg SM, Kopin IJ. Stimulation-induced release of serotonin. Advances in Pharmacology. 6: 351-64. PMID 4298804 DOI: 10.1016/S1054-3589(08)61191-6  0.458
1967 Chase TN, Breese GR, Kopin IJ. Serotonin release from brain slices by electrical stimulation: regional differences and effect of LSD. Science (New York, N.Y.). 157: 1461-3. PMID 6037863 DOI: 10.1126/Science.157.3795.1461  0.419
1967 Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. The American Journal of Psychiatry. 124: 600-8. PMID 4383104 DOI: 10.1176/Ajp.124.5.600  0.493
Show low-probability matches.